Ignite Creation Date:
2025-12-25 @ 2:59 AM
Ignite Modification Date:
2026-03-03 @ 12:02 AM
Study NCT ID:
NCT05831033
Status:
RECRUITING
Last Update Posted:
2024-09-19
First Post:
2023-04-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of an Autologous Tumor Infiltrating Lymphocyte (TIL) Therapy in Patients with Advanced Solid Tumors
Sponsor:
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-05-23
Start Date Type:
ACTUAL
Primary Completion Date:
2027-02-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-06-15
Completion Date Type:
ESTIMATED
First Submit Date:
2023-04-14
First Submit QC Date:
None
Study First Post Date:
2023-04-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-14
Last Update Post Date:
2024-09-19
Last Update Post Date Type:
ACTUAL